Results 191 to 200 of about 3,048 (216)

Non-immunoglobulin scaffolds: a focus on their targets

Trends in Biotechnology, 2015
Ales Berlec, Borut Strukelj
exaly  

Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease

Circulation, 2006
Tohru Kobayashi, Tomio Kobayashi, Kazushi Tamura   +2 more
exaly  

Immunoglobulin-M

2011
openaire   +1 more source

Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Circulation, 2009
Myles J Lewis, Marina Botto, Joseph J Boyle   +2 more
exaly  

Targeting Adhesion Molecules as a Potential Mechanism of Action for Intravenous Immunoglobulin

Circulation, 2005
Paul Kubeš, Christopher Doig
exaly  

An Update on the Use of Immunoglobulin for the Treatment of Immunodeficiency Disorders

Immunotherapy, 2014
Charlotte Cunningham-Rundles
exaly  

Immunoglobulin-M

2006
openaire   +1 more source

Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis

American Journal of Kidney Diseases, 1996
Frieder Keller
exaly  

Segmental flexibility of immunoglobulin M molecules

Immunochemistry, 1972
Y A, Zagyansky, L A, Tumerman, A M, Egorov   +2 more
openaire   +2 more sources

Altered hepatic transport of immunoglobulin A in mice lacking the J chain.

Journal of Experimental Medicine, 1995
Seidman J G
exaly